# OnCo record nct02945033 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02945033/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02945033", "NCT02945033" ;
  schema:name "Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk"@en ;
  schema:alternateName "ASPIK French"@en ;
  schema:description "A phase 3 trial in colorectal cancer, run by University Hospital, Rouen, active but no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct02945033/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02945033> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/colon-cancer/> .